OLP-1002
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OLP-1002, covering 2021-08-26 to 2024-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint [Phase 2]